Intercellular adhesion molecule‐3 is the predominant co‐stimulatory ligand for leukocyte function antigen‐1 on human blood dendritic cells
- 1 September 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (9) , 2528-2532
Abstract
Dendritic cells (DC) are potent stimulators of primary T lymphocyte responses to foreign antigen. The initial DC‐T lymphocyte interaction involves the binding of the adhesion molecule leukocyte function antigen‐1 (LFA‐1; CD11a/CD18) on the T lymphocyte to an intercellular adhesion molecule (ICAM) on the DC. Although blood and tonsil DC express ICAM‐1 (CD54) and ICAM‐2 (CD102) on their surface, anti‐ICAM‐1 and anti‐ICAM‐2 monoclonal antibodies (mAb) have little inhibitory activity on the DC‐stimulated mixed leukocyte reaction (MLR). We therefore examined the expression of the more recently identified LFA‐1 ligand, ICAM‐3 (CD50), in comparison to ICAM‐1 and ICAM‐2 on blood DC and sought a functional role for ICAM‐3 in DC‐mediated T lymphocyte responses. Resting blood DC expressed significantly more ICAM‐3 than ICAM‐1 or ICAM‐2 as assessed by flow cytometry. Treatment of resting DC with interferon‐γ led to increased expression of ICAM‐1; however, ICAM‐2 and ICAM‐3 levels remained relatively constant. Solid‐phase recombinant chimeric molecules ICAM‐1‐, ICAM‐2‐ and ICAM‐3‐Fc were able to co‐stimulate CD4+T lymphocyte proliferation in conjunction with suboptimal solid‐phase CD3 mAb 64.1. However, the anti‐ICAM‐3 mAb CAL 3.10 inhibited a DC‐stimulated MLR to a greater extent than anti‐ICAM‐1 or anti‐ICAM‐2 reagents and appeared to act by blocking the DC ICAM‐3‐ T lymphocyte LFA‐1 interaction. As ICAM‐3 is the predominant LFA‐1 ligand on resting blood DC, we postulate that DC may utilize ICAM‐3 for initial DC‐T lymphocyte interactions, and that ICAM‐1, which is up‐regulated upon DC activation, and/or ICAM‐2, may contribute to DC migration or later phases of the T lymphocyte activation process.Keywords
This publication has 34 references indexed in Scilit:
- Activation of human peripheral blood dendritic cells induces the CD86 co‐stimulatory moleculeEuropean Journal of Immunology, 1995
- Epitope mapping and functional properties of anti‐intercellular adhesion molecule‐3 (CD50) monoclonal antibodiesEuropean Journal of Immunology, 1995
- ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway.Journal of Cell Biology, 1993
- ICAM‐3, the third LFA‐1 counterreceptor, is a co‐stimulatory molecule for both resting and activated T lymphocytesEuropean Journal of Immunology, 1993
- Intercellular Adhesion Molecule-2 (ICAM-2) Expression on Human Dendritic CellsCellular Immunology, 1993
- Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptors for lymphocyte function-associated antigen 1.Journal of Experimental Medicine, 1993
- Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.Journal of Experimental Medicine, 1992
- Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.Journal of Experimental Medicine, 1991
- Involvement of the CDw50 molecule in allorecognitionTissue Antigens, 1990
- The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirusCell, 1990